AstraZeneca to build €300m manufacturing plant in Ireland

The planned investment at the Alexion Campus in College Park, Dublin, is expected to create about 100 direct jobs, including scientist and engineering positions, as well as further indirect jobs

The project will be AstraZeneca's first-ever manufacturing facility in Ireland. File Picture: PA Photos.

AstraZeneca has announced that it will be establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, at a cost of over €300m. 

In a statement, the firm behind the Covid vaccine said the facility would "ensure the company’s global supply network is fit for future growth".